Please use this identifier to cite or link to this item:
|Title:||LIN28/LIN28B: An emerging oncogenic driver in cancer stem cells||Authors:||Zhou, J.
|Keywords:||Cancer stem cell (CSC)
Tumor initiating cell (TIC)
|Issue Date:||May-2013||Citation:||Zhou, J., Ng, S.-B., Chng, W.-J. (2013-05). LIN28/LIN28B: An emerging oncogenic driver in cancer stem cells. International Journal of Biochemistry and Cell Biology 45 (5) : 973-978. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biocel.2013.02.006||Abstract:||LIN28 (LIN28A) is a reprogramming factor and conserved RNA-binding protein. LIN28B is the only homolog of LIN28 in humans, sharing structure and certain function. LIN28/LIN28B has been identified to be overexpressed in a wide range of solid tumors and hematological malignancies. Blockage of let-7 miRNA biogensis and subsequent derepression of let-7 miRNA target genes by LIN28/LIN28B play important roles in cancer progression and metastasis. We will first provide an overview of LIN28/LIN28B gene and protein structures, followed by summary of the studies that showed their aberrant expression in primary human cancers and relevant clinical significance with emphasis on their roles in formation of cancer stem cells. Next, we will highlight the current knowledge of LIN28/LIN28B regulators and molecular mechanisms of LIN28/LIN28B-mediated oncogenesis. The potential medical applications for targeting LIN28/LIN28B will also be discussed in this review. © 2013 Elsevier Ltd.||Source Title:||International Journal of Biochemistry and Cell Biology||URI:||http://scholarbank.nus.edu.sg/handle/10635/110818||ISSN:||13572725||DOI:||10.1016/j.biocel.2013.02.006|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Apr 5, 2020
WEB OF SCIENCETM
checked on Mar 26, 2020
checked on Mar 28, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.